Brief: Shield Therapeutics Says Signed Licence Agreement In Japan For Accrufer
22/04/2025 07:08
April 22 (Reuters) - Shield Therapeutics PLC STXS.L: SHIELD THERAPEUTICS - LICENCE AGREEMENT IN JAPAN FOR ACCRUFER® SHIELD THERAPEUTICS - TO GET INITIAL PAYMENT OF ABOUT $665,000 PLUS REGULATORY & SALES MILESTONES, & DOUBLE-DIGIT ROYALTIES ON NET SALES Source text: ID:nRSV6440Fa Further company coverage: STXS.L ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shield Therapeutics
See all newsBrief: Shield Therapeutics To Assume Full Commercial Control Of ACCRUFeR In US
Shield Therapeutics - Shield assumes full control of ACCRUFeR® in the US
Shield Therapeutics - Interim results for the six months ended 30 Jun 26
Brief: Shield Therapeutics Says On Track For Profitability In 2026; Appoints Michael Jensen As CFO
Shield Therapeutics - Q2 and H1 2026 Trading Update